Pentatrichomonas hominis is a flagellated protozoan found in the large intestine. CDC places it among nonpathogenic intestinal flagellates. Despite its name, a stool finding is not a diagnosis of the sexually transmitted infection caused by Trichomonas vaginalis.
On this page
What is distinctive about its life cycle
CDC describes P. hominis as occurring in a trophozoite form, with no known cyst stage. This differs from several other intestinal protozoa. Its presence may indicate fecal exposure, but cannot establish the source or timing of that exposure. [1]
What the GI-MAP target means
GI-MAP includes a P. hominis DNA target. Molecular detection does not show living trophozoites under a microscope, demonstrate intestinal injury or prove that the finding explains symptoms. The target is specific to the reported organism, not every species with a similar name. [2]
How to approach symptoms alongside detection
Persistent diarrhea or abdominal discomfort still deserves a clinical assessment. The nonpathogenic classification means the detected organism should not be assumed to be the cause. Other infections and noninfectious explanations may be more relevant.
If another laboratory test disagrees, compare methods and dates with the clinician. A molecular assay and microscopy can differ in target and specimen requirements; the number of positive lines is not a way to decide which explanation is correct.
Why automatic parasite treatment is not the goal
Ask what condition is being treated and what evidence supports that decision. A report can identify organisms that do not require eradication simply because they are unfamiliar. Avoid choosing a cleanse or prescription from the label alone.
Common questions
Is this trichomoniasis?
No. P. hominis in stool is different from Trichomonas vaginalis infection. Genital symptoms need their own assessment and appropriate test.
Can a negative result exclude all protozoa?
No. It addresses the named target in the submitted sample, not every intestinal organism.
Sources and review
Sources checked October 7, 2026. Manufacturer material describes the test; clinical guidance and research support the interpretation limits.
- CDC DPDx: Nonpathogenic flagellates
- Diagnostic Solutions Laboratory: GI-MAP interpretive guide (manufacturer specifications)
Medical review of this article is pending. For a correction or source question, contact GI MAP Test.